Trading a short squeeze is a popular strategy because the stock price can go beyond real valuation. The way it works is traders borrow a certain stock, they sell it with the hope of buying it back cheaper and returning the stock to the lender. However, when millions of shares are bought back, it’s likely to drive the stock price higher, which is how you can profit.

Because the interest for shorted stocks remains, Finbold analyzed the most shorted stocks this year on August 31 and selected the two with the highest potential to soar in the future as the market prepares to head into September.

Novavax (NASDAQ: NVAX)

Novavax is a biotech company that develops and commercializes vaccines to prevent serious diseases. The company has developed a COVID-19 vaccine, and now with the re-emergence of new strains, it could provide a good marketplace for its products.

The company is one of the most shorted stocks at 45.79% of the float, as of August data. In other words, almost 40 million shares are shorted out of 86 million shares floating. If a short squeeze happens, it could be massive.

Morningstar’s equity report has put a fair value of $17.57 per share. That’s 110% above the current market price of $8.36.

Morningstar quantitative equity report for NVAX. Source: Interactive Brokers Fundamentals Explorer

Fisker Inc (NYSE: FSR)

Fisker is a California-based electric vehicle manufacturer. For the moment, Fisker sells only one vehicle, the Fisker Ocean, which is an all-electric SUV. More vehicles are being designed and developed, though, like the Ronin sports car and the Alaska lightweight pick-up truck.

READ MORE -  Why Nikola (NKLA) Stock Could Begin a Comeback

The company is one of the top 10 most shorted stocks with 42.57% of the float, as of August data. That’s an increase from 25% a month ago. 

Morningstar’s equity report has provided a $9.51 fair value for the FSR stock. With the stock currently trading at $5.79, that’s a 64% difference.

Morningstar quantitative equity report for FSR. Source: Interactive Brokers Fundamentals Explorer

Novavax is down 14% year to date, while Fisker is down 15% during the same period. The S&P 500’s 18% return has outperformed both so far.

Buy stocks now with Interactive Brokers – the most advanced investment platform

Disclaimer: The content on this site should not be considered investment advice. Investing is speculative. When investing, your capital is at risk.

The post Short squeeze alert: Two stocks that could take off in September appeared first on Finbold.

Avatar photo
Dennis is a business and financial writer, who had spent almost his entire life independently reporting on different business ventures with major impact on the US and global economy. Dennis places a special focus on examining tech stocks, biotech stocks all while investing a great part of his early hours to researching and writing on the companies in the US markets. Dennis has 15+ years of experience in financial markets.